Threshold Pharmaceuticals, Inc. Stock Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 12.7M | Sales 2025 * | 1.37M | Capitalization | 8.06M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -34M | EV / Sales 2024 * | 0.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.9 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Jason Kim
PSD | President | 49 | 09-12-31 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Harold Selick
CHM | Chairman | 69 | 17-07-31 |
David Hoffmann
BRD | Director/Board Member | 79 | 17-07-31 |
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.38% | 21.31B | |
-16.61% | 21.21B | |
-5.20% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |